These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1153 related items for PubMed ID: 17918088

  • 1. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 2. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 01; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Mar 01; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 5. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 07; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 6. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.
    J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901
    [Abstract] [Full Text] [Related]

  • 7. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E.
    AIDS; 2006 Jun 12; 20(9):1253-60. PubMed ID: 16816553
    [Abstract] [Full Text] [Related]

  • 8. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P, Trabaud MA, Pradat P, Lebouché B, Chevallier M, Chevallier P, Zoulim F, Trepo C.
    Clin Infect Dis; 2007 Sep 01; 45(5):624-32. PubMed ID: 17682999
    [Abstract] [Full Text] [Related]

  • 9. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct 01; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 11. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA.
    Int J STD AIDS; 2009 May 01; 20(5):336-8. PubMed ID: 19386971
    [Abstract] [Full Text] [Related]

  • 12. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep 01; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 13. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB, Torresi J, Lemoh C, Biggs BA.
    J Med Virol; 2008 Sep 01; 80(9):1565-9. PubMed ID: 18649341
    [Abstract] [Full Text] [Related]

  • 14. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A.
    Intervirology; 2008 Sep 01; 51(4):270-4. PubMed ID: 18841029
    [Abstract] [Full Text] [Related]

  • 15. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
    Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M.
    Int J STD AIDS; 2008 Mar 01; 19(3):197-9. PubMed ID: 18397562
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V.
    J Med Virol; 2010 Feb 01; 82(2):206-12. PubMed ID: 20029819
    [Abstract] [Full Text] [Related]

  • 17. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
    Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C.
    Clin Infect Dis; 2003 Jun 15; 36(12):1602-5. PubMed ID: 12802762
    [Abstract] [Full Text] [Related]

  • 18. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr 15; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 19. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan 15; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 20. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.